SCHEMBL27068272

SCHEMBL27068272

O=c1c2[nH]c(CN3CCCCC3)cc2c(C2CC2)cn1-c1cccc(C2(c3nnco3)CC(F)(F)C2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27041435 0.93 CBLB (0.36) —
SCHEMBL27068119 0.85 CBLB (0.40) —
SCHEMBL27068278 0.82 CBLB (0.35) —
SCHEMBL30728175 0.81 CBLB (0.39) —
SCHEMBL27068276 0.81 CBLB (0.39) —
SCHEMBL27068273 0.80 BRD4 (0.32) —
SCHEMBL27068170 0.80 CBLB (0.40) —
SCHEMBL30728232 0.80 CBLB (0.48) —
SCHEMBL27068275 0.79 BRD4 (0.32) —
SCHEMBL27068115 0.79 CBLB (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024020034-A1 CBL-B INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2024-01-25 — — WO disclosed
Send feedback